{"title":"Forced degradation and stability assessment of Tenofovir alafenamide","authors":"Rahul Kumar, Sandeep Malik","doi":"10.47587/dpsa.2023.3306","DOIUrl":"https://doi.org/10.47587/dpsa.2023.3306","url":null,"abstract":"This study presents a comprehensive evaluation of an analytical method for the quantification and identification of Tenofovir Alafenamide (TAF) and its related impurities in pharmaceutical formulations. The method exhibited outstanding performance, with exceptional sensitivity demonstrated through low limits of detection (LOD) and quantification (LOQ) values for TAF and various impurities. The LOD and LOQ values for TAF were determined to be 0.001% and 0.004%, respectively, underscoring the method's capability to detect minute concentrations. System suitability assessments, including LOD verification, linearity studies, relative response factor (RRF) determination, and accuracy assessments, provided a comprehensive understanding of the method's reliability and precision. The method showed a strong linear relationship between concentration and peak area, along with accurate recovery of added compound amounts at various concentration levels. Forced degradation studies further validated the method's specificity and robustness, with degradation peaks distinct from TAF and its specified impurities. Peak purity analysis confirmed the method's ability to accurately determine TAF in both untreated and treated test preparations. Additionally, system precision, method precision, and intermediate precision evaluations showcased the method's consistent and reproducible performance under various conditions and across different analysts. Stability assessments of the analytical solution, standard preparation, and mobile phase revealed the method's resilience to variations in flow rate and column oven temperature, with most parameters remaining within acceptable limits. In conclusion, this analytical method is a reliable tool for the precise quantification and identification of TAF and related impurities, meeting stringent acceptance criteria. Its robustness, precision, and specificity make it suitable for pharmaceutical quality control","PeriodicalId":470262,"journal":{"name":"Drug and Pharmaceutical Science Archives","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136258853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Analytical method validation for tenofovir alafenamide and known impurities","authors":"Rahul Kumar, Sandeep Malik","doi":"10.47587/dpsa.2023.3305","DOIUrl":"https://doi.org/10.47587/dpsa.2023.3305","url":null,"abstract":"This study comprehensively validates an analytical method for assessing Tenofovir alafenamide and its related impurities using UPLC. The results demonstrate that the method is highly specific, accurate, precise, linear, and robust. Specificity analysis confirms that the method exhibits high selectivity, with no interfering peaks observed at the retention time of Tenofovir alafenamide or its specified impurities when compared to blank diluents. The peaks for Tenofovir alafenamide and its known impurities are well resolved from each other and from potential blank peaks, as confirmed by peak purity analysis. Linearity is established for various impurities in relation to the limit of detection (LOD) and limit of quantification (LOQ). Accuracy testing reveals that most impurities exhibit recoveries within acceptable ranges at different concentration levels, with low %RSD values indicating method accuracy. The method's range is justified for concentrations spanning from the LOQ to 150% of the test concentration, supported by precision, linearity, and accuracy characteristics within this range. Robustness is confirmed through parameter variations, ensuring consistent results under different conditions. Stability studies show that the standard preparation remains stable for up to 13 hours when stored at 8°C, with immediate injection recommended for system suitability and test preparations. The mobile phase remains stable for 79 hours at room temperature. In conclusion, this validated UPLC method is suitable for routine analysis of Tenofovir alafenamide Fumarate and its related substances. It meets all necessary criteria for reliable analysis and exhibits high selectivity and robustness.","PeriodicalId":470262,"journal":{"name":"Drug and Pharmaceutical Science Archives","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136256710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rohini C. Kolhe, Shweta P. Ghode, Rishikesh S. Shingi, Suvarna A. Vadje
{"title":"Formulation and evaluation of polyherbal cream using Murraya koengii, Nyctanthus arbortristis and Ixora coccinea leaves hydro-alcoholic extract","authors":"Rohini C. Kolhe, Shweta P. Ghode, Rishikesh S. Shingi, Suvarna A. Vadje","doi":"10.47587/dpsa.2023.3302","DOIUrl":"https://doi.org/10.47587/dpsa.2023.3302","url":null,"abstract":"This research aimed to formulate and evaluate a polyherbal cream utilizing Murraya koengii , Nyctanthus arbortristis and Ixora coccinea leaves hydro-alcoholic extract to assess its potential antimicrobial effects. The cream was formulated using a cream base comprising bee's wax, mineral oil, borax, Paraffin wax, cetyl alcohol, phenol, distilled water","PeriodicalId":470262,"journal":{"name":"Drug and Pharmaceutical Science Archives","volume":"82 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135311279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comprehensive morpho-physicochemical and phytochemical analysis of Ziziphus oenoplia bark","authors":"Anshu Mishra, Vandana Yadav","doi":"10.47587/dpsa.2023.3303","DOIUrl":"https://doi.org/10.47587/dpsa.2023.3303","url":null,"abstract":"Ziziphus oenoplia , a member of the Rhamnaceae family, has garnered attention for its medicinal properties. The fruit of this plant has been traditionally used to alleviate stomach pain, while the bark's decoction has been employed to facilitate wound healing. Additionally, the presence of cyclopeptide alkaloids in the plant has been associated with anti-inflammatory and anti-cholinergic activities. This study presents a thorough examination of the morphological and physicochemical attributes of the bark of Ziziphus oenoplia , complemented by a comprehensive phytochemical screening utilizing various solvents for successive extraction. The macroscopic assessment unveiled distinct features of the bark, characterized by its rough, greenish-brown upper surface with thorns, and a smooth, green lower surface. Moreover, palmate venation patterns were observed, contributing to the pharmacognostical characterization of this botanical specimen. Physicochemical evaluations, including ash values, moisture content, pH, and conductivity, provided essential insights into the composition and quality of the bark. The ash values indicated the presence of inorganic content, with variations in acid-insoluble ash, water-soluble ash, alcohol-soluble ash, and sulphated ash, crucial for assessing purity. Furthermore, pH measurements revealed the alkaline nature of leaf ash and the mildly acidic character of the water extract, contributing to a better understanding of the plant's chemical properties. The study also explored the concentration of heavy metals, indicating relatively high levels of sodium and potassium but low concentrations of mercury and arsenic in the bark extract. Additionally, extractive values in various solvents highlighted the highest extractive value in alcohol, followed by chloroform and water, and described the physical characteristics of the extracts. Finally, the phytochemical screening identified a diverse range of bioactive compounds, including carbohydrates, alkaloids, saponin glycosides, steroids, proteins, amino acids, starch, and tannins in the bark extract. These findings provide valuable insights into the potential medicinal properties of Ziziphus oenoplia , opening doors for further research and applications in herbal medicine and botanical studies. It is important to note that the choice of solvent during extraction significantly influences the types and quantities of phytoconstituents obtained, emphasizing the need for careful consideration in future investigations.","PeriodicalId":470262,"journal":{"name":"Drug and Pharmaceutical Science Archives","volume":"2011 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136256709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Synthesis & biological evaluation of quinolone triazole Schiff base","authors":"Vandana Yadav, Anshu Mishra","doi":"10.47587/dpsa.2023.3304","DOIUrl":"https://doi.org/10.47587/dpsa.2023.3304","url":null,"abstract":"Triazole is a heterocyclic aromatic organic compound for prevention and treatment of parasitic infections. Divers literature survey either as single heterocyclic derivatives or in fusion with the other cycles, these heterocycle is emerging as the most explored center to obtain clinically significant. The nitrogen containing heterocycles are found in abundance in most of the medicinal chemistry. A large variety of 4-substituted Triazole derivatives show very promising and excellent therapeutic effectiveness. The major activities exhibited by these derivatives include insecticidal, antifungal, antiviral, antibacterial, sedative, hypnotic, anticonvulsant, hypoglycemic, antidepressant, antitubercular, analgesic, anti-malarial and anticancer agents, and anti-inflammatory activities. The 1,2,4-triazole nucleus has been incorporated into a wide variety of therapeutically interesting drug candidates including H1/H2 histamine receptor blockers, cholinesterase active agents, CNS stimulants, antianxiety, and sedatives agents. Triazole drugs are widely used shows that among the triazole derivatives, 4-substituted ones are found to be pharmacologically more potent and hence the design and synthesis of 4-substituted triazole are the potential area of research. Extensive biochemical and pharmacological studies have confirmed that its derivatives are effective against various strains of microorganisms. In the present study 14 novel quinolone triazole Schiff bases have been synthesized viz VPD1-7. The synthesized derivatives have been biologically screened for their antibacterial and antifungal activity. Some of the synthesized derivatives have shown a very potent antibacterial and antifungal activity against various strains of bacteria and fungus respectively. Some of the compounds like VPD2, VPD3, VPD4, VPD6, have been found to possess antibacterial comparing with ciprofloxacin as standard, whereas VPD2, VPD3, VPD4, have been found highly active derivatives comparing with fluconazole as standard.","PeriodicalId":470262,"journal":{"name":"Drug and Pharmaceutical Science Archives","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136256716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}